Title | Type | SJR | H index | Total Docs. (2017) | Total Docs. (3years) | Total Refs. (2017) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2017) | %Female (2017) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | npj Breast Cancer | journal | 46 | 48 | 40 | 2007 | 146 | 37 | 3.65 | 41.81 | 50.68 | ||
52 | Best Practice and Research in Clinical Haematology | journal | 1.260 Q2 | 81 | 45 | 112 | 2554 | 258 | 105 | 2.04 | 56.76 | 41.67 | |
53 | Molecular Therapy - Oncolytics | journal | 1.193 Q2 | 42 | 34 | 66 | 1695 | 241 | 64 | 3.87 | 49.85 | 39.01 | |
54 | Experimental Hematology and Oncology | journal | 0.842 Q2 | 42 | 32 | 93 | 1249 | 247 | 90 | 2.98 | 39.03 | 41.75 | |
55 | Cancer Imaging | journal | 1.012 Q2 | 64 | 30 | 108 | 859 | 344 | 104 | 3.23 | 28.63 | 28.10 | |
56 | Cancer Treatment and Research Communications | journal | 0.250 Q3 | 23 | 29 | 117 | 1022 | 54 | 117 | 0.43 | 35.24 | 32.56 | |
57 | Precision Radiation Oncology | journal | 8 | 22 | 0 | 564 | 0 | 0 | 0.00 | 25.64 | 42.98 | ||
58 | European Oncology and Haematology | journal | 0.137 Q4 | 8 | 21 | 70 | 1209 | 13 | 50 | 0.16 | 57.57 | 44.00 | |
59 | Hereditary Cancer in Clinical Practice | journal | 0.848 Q2 | 31 | 20 | 56 | 878 | 136 | 53 | 2.43 | 43.90 | 55.36 | |
60 | Leukemia Research Reports | journal | 0.702 Q3 | 16 | 18 | 66 | 336 | 89 | 64 | 1.10 | 18.67 | 52.94 | |
61 | Cardio-Oncology | journal | 21 | 7 | 15 | 237 | 32 | 14 | 2.13 | 33.86 | 39.39 | ||
62 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 13 | 4 | 0 | 241 | 0 | 0 | 0.00 | 60.25 | 40.00 | ||
63 | npj Precision Oncology | journal | 36 | 1 | 0 | 67 | 0 | 0 | 0.00 | 67.00 | 25.00 | ||
64 | Breast Cancer Management | journal | 0.556 Q3 | 2 | 0 | 3 | 0 | 3 | 3 | 1.00 | 0.00 | 0.00 | |
65 | Chinese Journal of Cancer | journal | 1.516 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
66 | Colorectal Cancer | journal | 0.111 Q4 | 2 | 0 | 4 | 0 | 0 | 2 | 0.00 | 0.00 | 0.00 | |
67 | European Journal of Cancer, Supplement | journal | 1.358 Q1 | 29 | 0 | 22 | 0 | 76 | 20 | 0.30 | 0.00 | 0.00 | |
68 | Head and Neck Oncology (discontinued) | journal | 0.104 Q4 | 44 | 0 | 24 | 0 | 4 | 23 | 0.50 | 0.00 | 0.00 | |
69 | Lung Cancer Management | journal | 0.129 Q4 | 5 | 0 | 6 | 0 | 1 | 6 | 0.00 | 0.00 | 0.00 | |
70 | Melanoma Management | journal | 0.120 Q4 | 14 | 0 | 16 | 0 | 4 | 16 | 0.22 | 0.00 | 0.00 | |
71 | Therapeutic Advances in Vaccines | journal | 2.769 Q1 | 5 | 0 | 6 | 0 | 62 | 6 | 0.00 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®